Kostic V, Przedborski S, Flaster E, Sternic N
Department of Neurology, School of Medicine, Belgrade, Yugoslavia.
Neurology. 1991 Feb;41(2 ( Pt 1)):202-5. doi: 10.1212/wnl.41.2_part_1.202.
We evaluated whether patients with young-onset Parkinson's disease (PD) (onset between 21 and 40 years) develop levodopa-induced dyskinesias and motor response fluctuations more frequently and earlier than patients with older-onset PD (onset after 40 years) by determining the period from levodopa introduction to development of dyskinesias or fluctuations in 25 young-onset (mean age at onset, 33.54 years) and in 25 matched older-onset PD patients (mean age at onset, 55.76 years). Young-onset PD patients had significantly higher frequency for both dyskinesias and fluctuations after both 3 and 5 years of levodopa. Young-onset PD patients also developed both levodopa-induced dyskinesias and fluctuations earlier than older-onset PD patients. We suggest that the introduction of levodopa therapy in patients with young onset PD should be postponed as long as possible.
我们通过确定从开始使用左旋多巴到出现运动障碍或运动反应波动的时间,评估早发型帕金森病(PD)(发病年龄在21至40岁之间)患者是否比晚发型PD患者(发病年龄在40岁之后)更频繁、更早地出现左旋多巴诱导的运动障碍和运动反应波动。我们纳入了25例早发型PD患者(发病时平均年龄33.54岁)和25例匹配的晚发型PD患者(发病时平均年龄55.76岁)。早发型PD患者在使用左旋多巴3年和5年后出现运动障碍和运动反应波动的频率均显著更高。早发型PD患者出现左旋多巴诱导的运动障碍和运动反应波动也比晚发型PD患者更早。我们建议,早发型PD患者应尽可能推迟开始左旋多巴治疗。